Authors:
Soper, DL
Milbank, JBJ
Mieling, GE
Dirr, MJ
Kende, AS
Cooper, R
Jee, WSS
Yao, W
Chen, JL
Bodman, M
Lundy, MW
De, B
Stella, ME
Ebetino, FH
Wang, YL
deLong, MA
Wos, JA
Citation: Dl. Soper et al., Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis, J MED CHEM, 44(24), 2001, pp. 4157-4169
Authors:
Soper, DL
Milbank, JBJ
Mieling, GE
Dirr, MJ
Kende, AS
Chen, R
Bodman, M
Lundy, MW
De, B
Stella, ME
Ebetino, FH
Wang, YL
deLong, MA
Wos, JA
Citation: Dl. Soper et al., Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis. (vol 44, pg 4157, 2001), J MED CHEM, 44(24), 2001, pp. 4307-4307
Authors:
deLong, MA
Amburgey, J
Taylor, C
Wos, JA
Soper, DL
Wang, YL
Hicks, R
Citation: Ma. Delong et al., Synthesis and in vitro evaluation of human FP-receptor selective prostaglandin analogues, BIOORG MED, 10(14), 2000, pp. 1519-1522
Authors:
Wang, YL
Wos, JA
Dirr, MJ
Soper, DL
deLong, MA
Mieling, GE
De, B
Amburgey, JS
Suchanek, EG
Taylor, CJ
Citation: Yl. Wang et al., Design and synthesis of 13,14-dihydro prostaglandin F-1 alpha analogues aspotent and selective ligands for the human FP receptor, J MED CHEM, 43(5), 2000, pp. 945-952
Authors:
Wang, YL
Soper, DL
Dirr, MJ
deLong, MA
De, B
Wos, JA
Citation: Yl. Wang et al., The synthesis and human FP receptor binding affinity of 13,14-dihydro prostaglandin F-1 alpha sulfonamides: Potential treatments for osteoporosis, CHEM PHARM, 48(9), 2000, pp. 1332-1337